Analytical Data
-
Gene name
omp1
- Application
-
Alternative Names
Major outer membrane porin, serovar D; MOMP; ompA; omp1; CT_681
-
Species
Others
-
Source
E. coli
-
Tag
C-Myc;N-10*His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q46409
-
Expression Region
L23-F393
-
Protein Length
Full Length of Mature Protein
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
OMP1 (Outer Membrane Protein 1) is a significant protein primarily found in the outer membrane of certain Gram-negative bacteria, such as *Acinetobacter baumannii* and *Pseudomonas aeruginosa*. Its role in bacterial pathogenicity, including adherence to host tissues and evasion of the immune response, has made it a focal point of research in microbiology and infectious diseases. OMP1's structure and function are also of interest due to its potential as a vaccine candidate and a target for antibiotic development. The study of recombinant OMP1 enables researchers to explore its immunogenic properties, facilitating the design of vaccines that could provide protection against infections caused by these pathogens. Furthermore, the production of recombinant OMP1 in suitable expression systems allows for detailed structural and functional analyses, which can enhance our understanding of its interactions with host cells. Given the rising concern over antibiotic resistance and the urgency to develop novel therapeutic strategies, the investigation of OMP1 holds promise for contributing to the development of effective interventions against bacterial infections. Thus, research into OMP1 not only deepens scientific understanding but also has practical implications for public health.
